<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00897377</url>
  </required_header>
  <id_info>
    <org_study_id>YP2008009</org_study_id>
    <nct_id>NCT00897377</nct_id>
  </id_info>
  <brief_title>Treatment Strategy for Low-grade Gliomas</brief_title>
  <official_title>Treatment Strategy for Low-grade Gliomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although the prognosis of patients with low-grade glioma (LGG) is generally good, recurrence
      seems unavoidable in some patients because of the infiltrative growth of the tumors. How to
      treat LGGs is still under controversy. The role of radiation therapy and chemotherapy in the
      treatment of LGG need to be further investigated. The purpose of this study is the following:

        1. to investigate the role of early radiation therapy in MRI-determined total resected
           LGGs;

        2. to compare the efficacy of early radiation therapy and that of initial chemotherapy in
           the LGGs without total resection.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty in recruiting patients
  </why_stopped>
  <start_date>December 2007</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of early radiation therapy in MRI-determined total resected LGGs: evaluated as 5-year progression-free survival.</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of early radiation therapy vs. initial chemotherapy with temozolomide in LGGs without total resection: evaluated as 5-year progression-free survival.</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Astrocytomas</condition>
  <condition>Oligodendrogliomas</condition>
  <condition>Oligoastrocytoma</condition>
  <arm_group>
    <arm_group_label>Total resection with early radiation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total resected LGGs treated with early radiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total resection without radiation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Total resected LGGs treated without radiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Residual LGGs with radiation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Residual LGGs treated with early radiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Residual LGGs with chemo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Residual LGGS treated with temozolomide</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation therapy</intervention_name>
    <arm_group_label>Total resection with early radiation</arm_group_label>
    <arm_group_label>Residual LGGs with radiation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Temozolomide</intervention_name>
    <arm_group_label>Residual LGGs with chemo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed newly diagnosed low-grade gliomas

          -  Karnofsky performance status of 60 or more

        Exclusion Criteria:

          -  Previous history of radiation therapy or chemotherapy for gliomas

          -  Pregnant or breast feeding

          -  Diagnosis of another malignancy may exclude subject from study

          -  Evidence or history of bleeding diathesis

          -  Evidence or history of hypersensitivity to temozolomide
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhongping Chen, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2009</study_first_submitted>
  <study_first_submitted_qc>May 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2009</study_first_posted>
  <last_update_submitted>August 4, 2014</last_update_submitted>
  <last_update_submitted_qc>August 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2014</last_update_posted>
  <responsible_party>
    <name_title>Zhongping CHEN</name_title>
    <organization>Department of Neurosurgery, Sun Yat-sen University Cancer Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astrocytoma</mesh_term>
    <mesh_term>Oligodendroglioma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temozolomide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

